These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 39116355)
1. Efficacy of Trametinib in Neurofibromatosis Type 1-Associated Gastrointestinal Stromal Tumors: A Case Report. Fukuda M; Mukohara T; Kuwata T; Sunami K; Naito Y JCO Precis Oncol; 2024 Aug; 8():e2300649. PubMed ID: 39116355 [TBL] [Abstract][Full Text] [Related]
2. Dramatic response to trametinib in a male child with neurofibromatosis type 1 and refractory astrocytoma. Knight T; Shatara M; Carvalho L; Altinok D; Poulik J; Wang ZJ Pediatr Blood Cancer; 2019 Jan; 66(1):e27474. PubMed ID: 30251337 [No Abstract] [Full Text] [Related]
5. [Gastrointestinal stromal tumors in neurofibromatosis type 1]. Bajor J Orv Hetil; 2009 Jan; 150(4):149-53. PubMed ID: 19144598 [TBL] [Abstract][Full Text] [Related]
6. Genomic Status of Peacock JD; Pridgeon MG; Tovar EA; Essenburg CJ; Bowman M; Madaj Z; Koeman J; Boguslawski EA; Grit J; Dodd RD; Khachaturov V; Cardona DM; Chen M; Kirsch DG; Maina F; Dono R; Winn ME; Graveel CR; Steensma MR Cancer Res; 2018 Jul; 78(13):3672-3687. PubMed ID: 29720369 [TBL] [Abstract][Full Text] [Related]
7. MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)-addicted neuroblastomas. Umapathy G; Guan J; Gustafsson DE; Javanmardi N; Cervantes-Madrid D; Djos A; Martinsson T; Palmer RH; Hallberg B Sci Signal; 2017 Nov; 10(507):. PubMed ID: 29184034 [TBL] [Abstract][Full Text] [Related]
8. Promises from trametinib in RAF active tumors. Sausville EA N Engl J Med; 2012 Jul; 367(2):171-2. PubMed ID: 22663012 [No Abstract] [Full Text] [Related]
9. Improved survival with MEK inhibition in BRAF-mutated melanoma. Flaherty KT; Robert C; Hersey P; Nathan P; Garbe C; Milhem M; Demidov LV; Hassel JC; Rutkowski P; Mohr P; Dummer R; Trefzer U; Larkin JM; Utikal J; Dreno B; Nyakas M; Middleton MR; Becker JC; Casey M; Sherman LJ; Wu FS; Ouellet D; Martin AM; Patel K; Schadendorf D; N Engl J Med; 2012 Jul; 367(2):107-14. PubMed ID: 22663011 [TBL] [Abstract][Full Text] [Related]
11. Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma. Tolcher AW; Patnaik A; Papadopoulos KP; Rasco DW; Becerra CR; Allred AJ; Orford K; Aktan G; Ferron-Brady G; Ibrahim N; Gauvin J; Motwani M; Cornfeld M Cancer Chemother Pharmacol; 2015 Jan; 75(1):183-9. PubMed ID: 25417902 [TBL] [Abstract][Full Text] [Related]
12. A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01. Perreault S; Larouche V; Tabori U; Hawkin C; Lippé S; Ellezam B; Décarie JC; Théoret Y; Métras MÉ; Sultan S; Cantin É; Routhier MÈ; Caru M; Legault G; Bouffet É; Lafay-Cousin L; Hukin J; Erker C; Jabado N BMC Cancer; 2019 Dec; 19(1):1250. PubMed ID: 31881853 [TBL] [Abstract][Full Text] [Related]
14. A phase IB trial of the oral MEK inhibitor trametinib (GSK1120212) in combination with everolimus in patients with advanced solid tumors. Tolcher AW; Bendell JC; Papadopoulos KP; Burris HA; Patnaik A; Jones SF; Rasco D; Cox DS; Durante M; Bellew KM; Park J; Le NT; Infante JR Ann Oncol; 2015 Jan; 26(1):58-64. PubMed ID: 25344362 [TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal stromal tumors: management of metastatic disease and emerging therapies. Vadakara J; von Mehren M Hematol Oncol Clin North Am; 2013 Oct; 27(5):905-20. PubMed ID: 24093167 [TBL] [Abstract][Full Text] [Related]
16. Erlotinib and Trametinib in Patients With Luo J; Makhnin A; Tobi Y; Ahn L; Hayes SA; Iqbal A; Ng K; Arcila ME; Riely GJ; Kris MG; Yu HA JCO Precis Oncol; 2021; 5():. PubMed ID: 34250388 [TBL] [Abstract][Full Text] [Related]
17. On the reliability of mitotic count on biopsy samples of gastrointestinal stromal tumors. Cananzi FC Eur J Surg Oncol; 2014 Apr; 40(4):486. PubMed ID: 24486076 [No Abstract] [Full Text] [Related]
18. Neurofibromatosis type 1 and GIST: is there a correlation? Valencia E; Saif MW Anticancer Res; 2014 Oct; 34(10):5609-12. PubMed ID: 25275063 [TBL] [Abstract][Full Text] [Related]
19. Response to trametinib treatment in progressive pediatric low-grade glioma patients. Selt F; van Tilburg CM; Bison B; Sievers P; Harting I; Ecker J; Pajtler KW; Sahm F; Bahr A; Simon M; Jones DTW; Well L; Mautner VF; Capper D; Hernáiz Driever P; Gnekow A; Pfister SM; Witt O; Milde T J Neurooncol; 2020 Sep; 149(3):499-510. PubMed ID: 33026636 [TBL] [Abstract][Full Text] [Related]
20. On the reliability of mitotic count on biopsy samples of gastrointestinal stromal tumors. Ricci R; Chiarello G; Vanella G; Larghi A Eur J Surg Oncol; 2014 Apr; 40(4):484-5. PubMed ID: 24486075 [No Abstract] [Full Text] [Related] [Next] [New Search]